National Comprehensive Cancer Network

Interactive CME


Educational Events & Programs

NCCN POLICY SUMMIT UPDATES  > Click here for the press release

On June 25, 2018, the National Comprehensive Cancer Network® (NCCN®) hosted a summit focused the impact of new innovations and the rapidly shifting health policy landscape on access to high-quality cancer care in the United States. Experts in the field identified strategies to ensure access to and affordability of innovation and novel therapies, reviewed current FDA policies intended to make oversight more effective and efficient, and discussed recent healthcare regulations and legislation and their real world implications for oncology stakeholders.

An article will be published in the fall of 2018 in Journal of the National Comprehensive Cancer Network―JNCCN.

Please check back often for additional updates regarding the summit. If you have any questions, please contact Alyssa Schatz, Director, Policy and Advocacy, U.S. and Global Development.

Supported by Adaptive Biotechnologies. Supported by AmerisourceBergen. Supported by an educational donation provided by Amgen. Supported by Apobiologix, a division of ApoPharma USA, Inc. Supported by Astellas. Supported by AstraZeneca through its NCCN Corporate Council Membership. Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. Supported by Celgene Corporation. Sponsored by Clovis Oncology, Inc. Sponsored by Dendreon. Supported by Eisai, Inc. Supported by EMD Serono. Supported by a non-restricted medical education grant from Gilead Sciences, Inc. Supported by HELSINN. Supported by Heron. Supported by Incyte Corporation. Supported by Janssen Pharmaceutical Companies of Johnson & Johnson. Supported by Juno Therapeutics. This activity is supported by a contribution from Lilly. Supported by an independent educational grant from Merck & Co., Inc. Sponsored by Novartis Pharmaceuticals Corporation. This activity was made possible by Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc. Supported by Regeneron. Sponsored by Sandoz, A Novartis Division. Supported by an unrestricted sponsorship from TESARO. Supported by Verastem.


Access the Library of White Papers!

NCCN offers a broad library of white papers from previous summits that may be pertinent to your organization.

View Supporter Opportunities.

NCCN offers organizations various supporter opportunities.